301 related articles for article (PubMed ID: 31603229)
1. Skeletal muscle wasting in chronic kidney disease: the emerging role of microRNAs.
Robinson KA; Baker LA; Graham-Brown MPM; Watson EL
Nephrol Dial Transplant; 2020 Sep; 35(9):1469-1478. PubMed ID: 31603229
[TBL] [Abstract][Full Text] [Related]
2. Organ Crosstalk Contributes to Muscle Wasting in Chronic Kidney Disease.
Wang XH; Price SR
Semin Nephrol; 2023 Mar; 43(2):151409. PubMed ID: 37611335
[TBL] [Abstract][Full Text] [Related]
3. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of muscle wasting in chronic kidney disease.
Wang XH; Mitch WE
Nat Rev Nephrol; 2014 Sep; 10(9):504-16. PubMed ID: 24981816
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs.
Chen R; Lei S; Jiang T; She Y; Shi H
Front Cell Dev Biol; 2020; 8():577010. PubMed ID: 33043011
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: a new therapeutic frontier for muscle wasting in chronic kidney disease.
Mak RH; Cheung WW
Kidney Int; 2012 Aug; 82(4):373-4. PubMed ID: 22846810
[TBL] [Abstract][Full Text] [Related]
7. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.
Yu R; Chen JA; Xu J; Cao J; Wang Y; Thomas SS; Hu Z
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):327-341. PubMed ID: 27897418
[TBL] [Abstract][Full Text] [Related]
8. Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions.
Soares RJ; Cagnin S; Chemello F; Silvestrin M; Musaro A; De Pitta C; Lanfranchi G; Sandri M
J Biol Chem; 2014 Aug; 289(32):21909-25. PubMed ID: 24891504
[TBL] [Abstract][Full Text] [Related]
9. Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications-A Narrative Review.
Cheng TC; Huang SH; Kao CL; Hsu PC
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682722
[TBL] [Abstract][Full Text] [Related]
10. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.
Wang XH; Mitch WE; Price SR
Nat Rev Nephrol; 2022 Mar; 18(3):138-152. PubMed ID: 34750550
[TBL] [Abstract][Full Text] [Related]
12. miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk.
Zhang A; Li M; Wang B; Klein JD; Price SR; Wang XH
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):755-770. PubMed ID: 29582582
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Dysregulation in Aging and Pathologies of the Skeletal Muscle.
McCormick R; Goljanek-Whysall K
Int Rev Cell Mol Biol; 2017; 334():265-308. PubMed ID: 28838540
[TBL] [Abstract][Full Text] [Related]
14.
Wang B; Zhang A; Wang H; Klein JD; Tan L; Wang ZM; Du J; Naqvi N; Liu BC; Wang XH
Theranostics; 2019; 9(7):1864-1877. PubMed ID: 31037144
[TBL] [Abstract][Full Text] [Related]
15. Irisin Ameliorated Skeletal Muscle Atrophy by Inhibiting Fatty Acid Oxidation and Pyroptosis Induced by Palmitic Acid in Chronic Kidney Disease.
Zhou T; Wang S; Pan Y; Dong X; Wu L; Meng J; Zhang J; Pang Q; Zhang A
Kidney Blood Press Res; 2023; 48(1):628-641. PubMed ID: 37717561
[TBL] [Abstract][Full Text] [Related]
16. Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease.
Organ JM; Srisuwananukorn A; Price P; Joll JE; Biro KC; Rupert JE; Chen NX; Avin KG; Moe SM; Allen MR
Nephrol Dial Transplant; 2016 Feb; 31(2):223-30. PubMed ID: 26442903
[TBL] [Abstract][Full Text] [Related]
17. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.
Lee DE; Brown JL; Rosa-Caldwell ME; Blackwell TA; Perry RA; Brown LA; Khatri B; Seo D; Bottje WG; Washington TA; Wiggs MP; Kong BW; Greene NP
Physiol Genomics; 2017 May; 49(5):253-260. PubMed ID: 28341621
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA in skeletal muscle development, growth, atrophy, and disease.
Kovanda A; Režen T; Rogelj B
Wiley Interdiscip Rev RNA; 2014; 5(4):509-25. PubMed ID: 24838768
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle atrophy in clinical and preclinical models of chronic kidney disease: A systematic review and meta-analysis.
Troutman AD; Arroyo E; Sheridan EM; D'Amico DJ; Brandt PR; Hinrichs R; Chen X; Lim K; Avin KG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):21-35. PubMed ID: 38062879
[TBL] [Abstract][Full Text] [Related]
20. Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease.
Zhang YY; Yang M; Bao JF; Gu LJ; Yu HL; Yuan WJ
BMC Nephrol; 2018 Feb; 19(1):45. PubMed ID: 29486729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
